mounjaro tirzepatide patent expiry us leads India obesity drug sales as generic semaglutide gains traction post In weight loss battle, Novo

GLP-1s may lower the risk of death in people with obesity, breast cancer Researchers also looked at how GLP-1s affect death in people with breast cancer and obesity who are on hormonal therapy

Caution is advised in patients with severe gastrointestinal disease, including severe gastroparesis, or a history of pancreatitis

Human PK Sustained GHRH-receptor activation could theoretically cause receptor downregulation or feedback suppression of endogenous GH secretion

See updated 2026 data, side effects, and how Canadians can access it

During a consultation, your provider at Injectco can help you determine if semaglutide is right for you

Drink at least 2 liters of water daily